A Review of Clinical Translation of Inorganic Nanoparticles

By A. Anselmo, S. Mitragotri. AAPS Journal, 2015

435 citations recorded by the source corpus.

Subfields: Biomaterials, Electronic, Optical and Magnetic Materials, Materials Chemistry

View Paper: https://www.semanticscholar.org/paper/e3fc3b1114b292e91b9882b8ddafc3d721c7a50a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. A. Anselmo
2. J. Moon
3. A. Schwendeman
4. Lukasz J. Ochyl
5. Rui Kuai
6. S. Mitragotri

In Electronic, Optical and Magnetic Materials

1. A. Schwendeman
2. Lukasz J. Ochyl
3. J. Moon
4. Rui Kuai
5. S. Mitragotri
6. A. Anselmo

In Materials Chemistry

1. A. Anselmo
2. A. Schwendeman
3. Lukasz J. Ochyl
4. J. Moon
5. Rui Kuai
6. S. Mitragotri

Citations in the corpus

• Nanoparticles in the clinic (2016, background): “Interestingly, the majority of colloidal iron-oxide imaging agents have been discontinued in the United States and most of Europe.(13) In addition to MRI contrast enhancers, particles can be used as intravenous ultrasound enhancing agents.”
• Designer vaccine nanodiscs for personalized cancer immunotherapy (2016, positive): “Importantly, sHDL has been previously manufactured for clinical testing and proven to be safe in humans with the maximum tolerated dose at ~2.2 g/m 2 , 24-26 a value one-to two-orders of magnitude greater than most polymeric or inorganic nanoparticles in clinical trials 27,28 .”